Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6061 AL 6075

Natural bioactive compounds as modulators of autophagy: A herbal approach to the management of neurodegenerative diseases

Nelson VK, Begum MY, Suryadevara PR, Madhuri Kallam SD, Panda SP, Bodapati A, Sanga V, Bishoyi AK, Ballal S, Monsi M, Walia C, Prasad GVS, Abomughaid MM, Shukla S, Chauhan P, Jha NK.

Eur J Pharmacol. 2025 Oct 15;1005:178003. doi: 10.1016/j.ejphar.2025.178003. Epub 2025 Jul 29.

Flavonoids and phenolic compounds: a promising avenue for neurodegenerative disease therapy

Şahin TÖ, Cemali Ö, Özdemir M, Ayten Ş, Ağagündüz D.

Turk J Biol. 2025 Oct 10;49(5):635-659. doi: 10.55730/1300-0152.2767. eCollection 2025.

The effects of ursodeoxycholic acid on Parkinson's disease, a mechanistic review of the recent evidence

Razavi SM, Esmaealzadeh N, Ataei M, Afshari N, Saleh M, Amini Y, Hasrati S, Ghazizadeh Hashemi F, Mortazavi A, Mohaghegh Shalmani L, Abdolghaffari AH.

Metab Brain Dis. 2025 Feb 1;40(2):115. doi: 10.1007/s11011-025-01542-9.

Doxycycline: An essential tool for Alzheimer's disease

Forloni G.

Biomed Pharmacother. 2025 Jul;188:118159. doi: 10.1016/j.biopha.2025.118159. Epub 2025 May 13.

cGAS-STING and neurodegenerative diseases: A molecular crosstalk and therapeutic perspective

Dhapola R, Paidlewar M, Kumari S, Sharma P, Vellingiri B, Medhi B, HariKrishnaReddy D.

Int Immunopharmacol. 2025 Jun 26;159:114902. doi: 10.1016/j.intimp.2025.114902. Epub 2025 May 21.

The microbiota-inflammasome-brain axis as a pathogenic mediator of neurodegenerative disorders

Sarkar SK, Gubert C, Hannan AJ.

Neurosci Biobehav Rev. 2025 Sep;176:106276. doi: 10.1016/j.neubiorev.2025.106276. Epub 2025 Jul 3.

Leveraging microbiome-based interventions to improve the management of neurodegenerative diseases: evidence for effects along the microbiota-gut-brain axis

Auclair-Ouellet N, Kassem O, Bronner S, Oula ML, Binda S.

Front Nutr. 2025 Dec 11;12:1699884. doi: 10.3389/fnut.2025.1699884. eCollection 2025.

Pridopidine, a Potent and Selective Therapeutic Sigma-1 Receptor (S1R) Agonist for Treating Neurodegenerative Diseases

Gershoni Emek N, Tan AM, Geva M, Fekete A, Abate C, Hayden MR.

Pharmaceuticals (Basel). 2025 Dec 17;18(12):1900. doi: 10.3390/ph18121900.

Beyond the Gut: Unveiling Butyrate's Global Health Impact Through Gut Health and Dysbiosis-Related Conditions: A Narrative Review

Kalkan AE, BinMowyna MN, Raposo A, Ahmad MF, Ahmed F, Otayf AY, Carrascosa C, Saraiva A, Karav S.

Nutrients. 2025 Apr 9;17(8):1305. doi: 10.3390/nu17081305.

Protocol considerations for multigenerational blinding of preimplantation genetic testing for a monogenic condition for Huntington disease: a case report

Raine S, Siegel DR, Rabkina L, Nassab P, Cervero A, Martinez-Conejero JA, Elfman H, Polotsky AJ.

F S Rep. 2025 Mar 27;6(2):201-205. doi: 10.1016/j.xfre.2025.03.007. eCollection 2025 Jun.

Nanotechnological Approaches for Mitochondrial Targeting in Neurodegenerative Diseases

Ergin AD.

Curr Top Med Chem. 2025;25(28):3251-3266. doi: 10.2174/0115680266397447250723073446.

Black gas, bright future: H(2)S based therapeutics for neurodegenerative disorders

Morris JL, Lee JJ, Morris RE, Miljkovic JL.

Neurotherapeutics. 2025 Oct;22(6):e00755. doi: 10.1016/j.neurot.2025.e00755. Epub 2025 Sep 24.

Advances in Autophagy-Lysosomal Pathway and Neurodegeneration via Brain-Gut Axis

Yao P, Han H.

Biomedicines. 2025 Jun 5;13(6):1390. doi: 10.3390/biomedicines13061390.

Dental Calculus Formation Rate: The Role of Salivary Proteome and Metaproteome

Cai W, Dubreuil N, Abu Nada L, Zhou WBS, Basiri T, Hadad A, Charde P, Ducret M, Tamimi F.

J Clin Periodontol. 2025 Apr;52(4):612-621. doi: 10.1111/jcpe.14142. Epub 2025 Feb 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias